Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Integra LifeSciences Holdings
IART
Integra LifeSciences Holdings
Aging Population And Digital Health Will Expand Medical Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
08 May 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$29.78
52.8% undervalued
intrinsic discount
15 Aug
US$14.05
Loading
1Y
-34.8%
7D
10.2%
Author's Valuation
US$29.8
52.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$29.8
52.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-501m
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.9b
Earnings US$151.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.32%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
11.60%
Calculation
US$151.73m
Earnings '28
x
21.30x
PE Ratio '28
=
US$3.23b
Market Cap '28
US$3.23b
Market Cap '28
/
78.91m
No. shares '28
=
US$40.97
Share Price '28
US$40.97
Share Price '28
Discounted to 2025 @ 11.64% p.a.
=
US$29.44
Fair Value '25